Insights & Guides
GLP-1 Weight Loss Blog
Expert insights on GLP-1 medications, insurance coverage, clinic comparisons, and weight loss tips.
All
City Guides
Conditions
Cost
Guide
Guides
Health
Insurance
Lifestyle
Medications
News
Regulatory
Research
Safety
Side-effects
Treatment
Weight-loss
news
FDA Approves Wegovy HD (7.2 mg): Higher-Dose Semaglutide Delivers Record Weight Loss
The FDA approved Wegovy HD, a higher 7.2 mg semaglutide dose showing 21% average weight loss. Availability, eligibility, and how it compares.
news
FDA Warning Letter to Novo Nordisk: What Ozempic and Wegovy Patients Should Know
The FDA issued a warning letter to Novo Nordisk over unreported potential side effects. Here is what it actually means for patients taking Ozempic or Wegovy.
news
GLP-1 Weight Loss Results: What the Latest Studies Show
Clinical trials and real-world data show strong weight loss on GLP-1 drugs. Key findings on semaglutide and tirzepatide effectiveness summarized.